<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//old.international-biopharma.com/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://old.international-biopharma.com/standard-hypothyroidism-treatment-inadequate-in-controlling-crucial-aspects-of-the-condition/</loc>
		<lastmod>2018-08-28T09:26:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/hot-pepper-compound-may-reduce-obesity/</loc>
		<lastmod>2018-08-28T09:24:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/cancer-cells-destroyed-with-two-antipsychotic-drugs/</loc>
		<lastmod>2018-08-28T09:19:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/2-proteins-show-promise-as-targets-for-treating-obesity/</loc>
		<lastmod>2018-08-24T10:53:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/researchers-find-potential-new-gene-therapy-for-blinding-disease/</loc>
		<lastmod>2018-08-24T10:42:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/c-cit-sensors-single-use-cell-culture-in-situ-technologies-for-the-simultaneous-automated-and-continuous-monitoring-of-glucose-and-lactate-in-cell-cultures/</loc>
		<lastmod>2018-08-24T10:37:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/scientists-may-have-cleared-gene-therapy-hurdle/</loc>
		<lastmod>2018-08-24T10:28:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/magnetic-microrobots-deliver-cells-into-living-animals/</loc>
		<lastmod>2018-08-24T10:17:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/trial-launched-to-treat-parkinsons-with-reprogrammed-stem-cells/</loc>
		<lastmod>2018-08-24T10:14:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/astellas-acquires-gene-therapy-company-quethera/</loc>
		<lastmod>2018-08-24T10:11:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/cell-and-gene-therapy-catapult-opens-manufacturing-centre-to-accelerate-growth-of-the-industry-in-the-uk/</loc>
		<lastmod>2018-08-24T10:01:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/laetus-launches-new-smartspect-camera/</loc>
		<lastmod>2018-08-20T10:46:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/peli-biothermal-opens-new-network-station-in-frankfurt/</loc>
		<lastmod>2018-08-20T10:39:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/gileads-kite-gadeta-to-develop-cell-therapies/</loc>
		<lastmod>2018-08-20T09:42:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/boehringer-ingelheim-licenses-global-rights-to-cystic-fibrosis-gene-therapy/</loc>
		<lastmod>2018-08-20T09:39:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/regeneron-and-bluebird-bio-collaborate-on-t-cells-in-100-million-deal/</loc>
		<lastmod>2018-08-20T09:25:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/synthetic-chemical-discovered-that-may-lead-to-glioblastoma-treatment/</loc>
		<lastmod>2018-08-20T09:20:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/boosting-cancer-immunotherapy-by-switching-off-a-protein/</loc>
		<lastmod>2018-08-07T15:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/ema-faces-higher-staff-losses-ahead-of-move-to-amsterdam/</loc>
		<lastmod>2018-08-07T14:45:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/epizyme-trims-back-blood-cancer-trials-for-lead-drug-stock-sinks/</loc>
		<lastmod>2018-08-07T14:32:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/correcting-sickle-cell-causing-mutation-with-efficient-crispr-cas9-genome-editing/</loc>
		<lastmod>2018-08-07T14:28:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/laekna-acquires-exclusive-rights-for-two-oral-akt-inhibitors/</loc>
		<lastmod>2018-08-07T14:14:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/akouos-raises-50m-to-take-hearing-loss-gene-therapy-into-humans/</loc>
		<lastmod>2018-08-07T14:06:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/mayo-clinic-pinpoints-genes-that-raise-the-risk-of-triple-negative-breast-cancer/</loc>
		<lastmod>2018-08-07T14:03:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/regeneron-bluebird-bio-partner-on-cell-therapy-development/</loc>
		<lastmod>2018-08-07T13:58:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/alder-biopharmaceuticals-to-host-conference-call-to-discuss-second-quarter-2018-financial-and-operating-results/</loc>
		<lastmod>2018-07-31T12:40:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/fda-rejects-insys-opioid-pain-spray/</loc>
		<lastmod>2018-07-31T12:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/3d-printed-scaffolds-can-regrow-damaged-nerves/</loc>
		<lastmod>2018-07-31T12:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/who-se-asia-region-parliamentarians-make-stronger-commitments/</loc>
		<lastmod>2018-07-31T12:32:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/mercks-keytruda-gets-approval-in-china-for-advanced-melanoma/</loc>
		<lastmod>2018-07-31T12:30:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/daiichi-acquires-another-adc-drug-through-glycotope-licensing-deal/</loc>
		<lastmod>2018-07-31T12:28:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/wockhardt-starts-manufacturing-and-rd-facility-in-dubai/</loc>
		<lastmod>2018-07-31T12:26:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/sanbio-receives-20-million-grant-from-cirm/</loc>
		<lastmod>2018-07-31T12:21:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/sales-of-roche-new-drugs-are-surging-will-that-be-enough/</loc>
		<lastmod>2018-07-27T15:02:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/gilead-ceo-milligan-out-ahead-of-turnaround-bid/</loc>
		<lastmod>2018-07-27T15:01:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/positive-alzheimers-results-from-biogen-eisai-spark-cautious-optimism/</loc>
		<lastmod>2018-07-27T15:00:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/gsk-signs-300m-genetic-testing-deal/</loc>
		<lastmod>2018-07-27T14:58:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/wuxi-stas-jinshan-site-passes-fourth-u-s-fda-inspection/</loc>
		<lastmod>2018-07-27T14:57:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/innovent-receives-ind-approval-to-initiate-clinical-trials-in-china/</loc>
		<lastmod>2018-07-27T14:56:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/find-dndi-to-support-malaysian-moh-for-approaching-hcv/</loc>
		<lastmod>2018-07-27T14:53:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/now-your-smartphone-camera-can-perform-clinical-urinalysis-at-home/</loc>
		<lastmod>2018-07-27T14:50:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/strengthen-efforts-to-immunize-5-million-unvaccinated-children-who/</loc>
		<lastmod>2018-07-20T13:41:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/leapfrog-acquires-majority-stake-in-ascent-meditech/</loc>
		<lastmod>2018-07-20T13:39:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/novotech-partners-with-asian-eye-institute/</loc>
		<lastmod>2018-07-20T13:38:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/trumps-drug-plan-picks-up-momentum-as-merck-lowers-some-prices/</loc>
		<lastmod>2018-07-20T13:37:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/tecentriq-misses-another-chance-to-catch-keytruda/</loc>
		<lastmod>2018-07-20T13:34:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/allergans-eye-drug-stacks-up-against-lucentis-but-wider-market-still-iffy/</loc>
		<lastmod>2018-07-20T13:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/novartis-picks-up-il-17-inhibitor-in-deal-worth-over-1b/</loc>
		<lastmod>2018-07-20T13:31:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/kite-and-gadeta-announce-strategic-collaboration-to-advance-gamma-delta-t-cell-receptor-technology-for-solid-tumors/</loc>
		<lastmod>2018-07-20T13:29:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/immatics-enters-into-a-strategic-partnership-with-genmab-to-develop-next-generation-bispecific-cancer-immunotherapies/</loc>
		<lastmod>2018-07-13T13:56:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/pharmakrysto-announces-licensing-agreement-with-rutgers-university-for-new-treatment-for-people-with-cystinuria/</loc>
		<lastmod>2018-07-13T13:39:52+00:00</lastmod>
		<image:image>
			<image:loc>https://old.international-biopharma.com/wp-content/uploads/2018/07/Julian-Howell-CEO-PharmaKrysto.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/antabio-completes-e-12-5m-series-a/</loc>
		<lastmod>2018-07-13T13:36:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/xbrane-and-stada-enter-into-a-co-development-agreement-for-xlucane/</loc>
		<lastmod>2018-07-13T13:34:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/qiagen-to-expand-biomarker-research-in-uk/</loc>
		<lastmod>2018-07-13T13:06:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/merck-inks-deal-with-chinas-xian-janssen-for-type-2-diabetes-drug/</loc>
		<lastmod>2018-07-13T13:04:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/global-bioinformatics-network-prasm-to-list-on-coinbene/</loc>
		<lastmod>2018-07-13T12:57:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/gt-healthcare-invests-26-6m-in-potrero-medical/</loc>
		<lastmod>2018-07-13T12:55:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/international-conference-on-molecular-biology-and-stem-cells/</loc>
		<lastmod>2018-07-06T11:13:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/ogt-expands-direct-sales-and-support-infrastructure-in-europe/</loc>
		<lastmod>2018-07-06T10:58:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/drug-device-companies-gave-docs-hospitals-8-4b-in-2017/</loc>
		<lastmod>2018-07-06T10:53:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/western-australia-to-get-new-biotech-hub/</loc>
		<lastmod>2018-07-06T10:46:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/kent-imaging-partners-with-serenagroup-for-wound-care/</loc>
		<lastmod>2018-07-06T10:44:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/iran-syria-sign-mou-for-academic-cooperation/</loc>
		<lastmod>2018-07-06T10:42:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/researchers-in-japan-devise-method-to-produce-steroid-antibiotics/</loc>
		<lastmod>2018-07-06T10:38:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/cannabics-pharma-clinches-clinical-trial-on-cannabics-sr-5mg-for-cacs/</loc>
		<lastmod>2018-07-06T10:32:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/blood-test-to-determine-best-timing-to-administer-drugs/</loc>
		<lastmod>2018-07-06T10:31:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/ahh-raises-50-million-from-sheares-healthcare/</loc>
		<lastmod>2018-07-06T10:29:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/napier-launches-ai-ml-powered-healthcare-assistant/</loc>
		<lastmod>2018-07-06T10:26:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/human-vaccines-project-and-seqirus-partner-to-advance-universal-flu-vaccine-research/</loc>
		<lastmod>2018-07-05T08:41:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/pharmamar-chugai-terminate-license-agreement-for-zepsyre/</loc>
		<lastmod>2018-06-29T13:58:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/plasticell-leads-gene-therapy-manufacturing-consortium/</loc>
		<lastmod>2018-06-29T13:55:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/nbe-therapeutics-closes-a-chf-20-million-financing-by-novo-holdings-a-s/</loc>
		<lastmod>2018-06-29T13:49:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/prestige-biopharma-and-alvogen-announce-license-and-supply-agreement-to-commercialize-prestiges-trastuzumab-biosimilar-hervelous-in-central-and-eastern-europe-singapore/</loc>
		<lastmod>2018-06-29T13:47:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/immunotherapy-advances-spur-new-look-at-cancer-vaccines/</loc>
		<lastmod>2018-06-29T13:19:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/orchard-therapeutics-appoints-jim-geraghty-as-chairman-of-its-board-of-directors/</loc>
		<lastmod>2018-06-29T13:15:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/lupin-mylan-to-commercialize-enbrel-biosimilar/</loc>
		<lastmod>2018-06-29T13:12:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/aptamer-group-uk-biotech-business-raises-2-2m-investment/</loc>
		<lastmod>2018-06-29T13:10:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/cellgenix-completed-first-step-of-facility-expansion-to-stay-on-top-of-the-increasing-demands-for-gmp-cell-culture-reagents/</loc>
		<lastmod>2018-06-22T10:45:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/the-international-society-for-stem-cell-research-brings-researchers-together-in-melbourne/</loc>
		<lastmod>2018-06-22T10:43:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/blood-vessel-forming-cells-involved-in-aggressive-brain-tumour/</loc>
		<lastmod>2018-06-22T10:40:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/wuxi-biologics-initiates-construction-of-a-integrated-adc-solution-center-in-china/</loc>
		<lastmod>2018-06-22T10:36:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/emulate-raises-36m-to-develop-organ-on-chip-tech/</loc>
		<lastmod>2018-06-22T10:29:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/nuance-enters-58-m-deal-for-non-opioid-pain-treatment-in-china/</loc>
		<lastmod>2018-06-22T10:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/alpha-biopharma-announces-series-a-financing/</loc>
		<lastmod>2018-06-22T09:16:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/path-sd-biosensor-partner-to-advance-malaria-treatment/</loc>
		<lastmod>2018-06-22T09:13:18+00:00</lastmod>
		<image:image>
			<image:loc>https://old.international-biopharma.com/wp-content/uploads/2018/06/1-11123.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/esco-group-acquires-at-medical-uab/</loc>
		<lastmod>2018-06-15T12:47:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/moxidectin-gets-usfda-nod-to-treat-river-blindness/</loc>
		<lastmod>2018-06-15T12:45:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/suven-life-sciences-gets-patents-in-china-and-us/</loc>
		<lastmod>2018-06-15T12:43:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/israeli-biotech-startups-to-get-new-workspace/</loc>
		<lastmod>2018-06-15T12:41:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/jhl-biotech-appoints-new-cfo-raises-106m/</loc>
		<lastmod>2018-06-15T12:39:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/chemaxon-and-aws-simplify-getting-scientists-moving-on-the-cloud/</loc>
		<lastmod>2018-06-15T12:37:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/extremely-fast-chemical-search-in-vast-chemical-space/</loc>
		<lastmod>2018-06-15T12:34:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/pfizer-expands-investment-in-biotech-through-pfizer-ventures/</loc>
		<lastmod>2018-06-15T12:31:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/wize-pharma-signs-distribution-agreement-in-china-for-lo2a/</loc>
		<lastmod>2018-06-08T15:00:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/athenex-appoints-christina-wang-as-vp-for-apac-operations/</loc>
		<lastmod>2018-06-08T14:58:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/nektars-sole-skeptic-warns-of-parallels-to-biggest-biotech-flop/</loc>
		<lastmod>2018-06-08T14:55:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/orchard-therapeutics-announces-appointments-of-marc-dunoyer-and-charlie-rowland-to-board-of-directors/</loc>
		<lastmod>2018-06-08T14:51:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/philips-sam-open-regional-oncology-centre-in-singapore/</loc>
		<lastmod>2018-06-08T14:50:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/vetter-strikes-out-on-new-pathways-to-further-develop-the-injection-process/</loc>
		<lastmod>2018-06-08T14:48:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/asco18-3-unanswered-questions-from-oncologys-largest-conference/</loc>
		<lastmod>2018-06-08T14:44:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/bio18-pfizer-sort-of-inches-back-to-neuro-building-ties-with-fda/</loc>
		<lastmod>2018-06-08T09:19:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/nice-annual-conference-2018/</loc>
		<lastmod>2018-06-01T10:51:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/johnson-johnson-has-the-most-bucks-for-biopharma-ma-astellas-the-easiest-target-analyst/</loc>
		<lastmod>2018-06-01T10:31:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/vtv-therapeutics-shares-soar-on-licensing-tie-up-with-chinese-group-newsoara-biopharma/</loc>
		<lastmod>2018-06-01T10:27:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/half-of-orphan-drug-sales-to-come-from-cancer-evaluate-finds/</loc>
		<lastmod>2018-06-01T10:23:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/therapeuticsmd-garners-fda-ok-for-imvexxy/</loc>
		<lastmod>2018-06-01T10:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/allergan-to-sell-off-womens-health-anti-infective-businesses/</loc>
		<lastmod>2018-06-01T10:10:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/fda-launches-medical-device-innovation-challenge-to-combat-opioid-crisis/</loc>
		<lastmod>2018-06-01T10:06:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/phrma-criticizes-icer-in-latest-skirmish-over-valuing-drugs/</loc>
		<lastmod>2018-06-01T10:00:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/vertex-crispr-gene-editing-therapy-hit-with-clinical-hold/</loc>
		<lastmod>2018-06-01T09:56:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/peptide-display-company-orbit-discovery-closes-6-9m-series-a-financing/</loc>
		<lastmod>2018-05-25T10:38:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/mundipharma-to-launch-web-based-chat-bot-for-feminine-care/</loc>
		<lastmod>2018-05-25T10:30:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/agendia-angsana-partner-for-cancer-treatment-in-southeast-asia/</loc>
		<lastmod>2018-05-25T10:28:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/venus-medtech-inks-strategic-partnership-with-keystone-heart/</loc>
		<lastmod>2018-05-25T10:25:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/gene-therapies-that-could-transform-diseases-get-easier-fda-path/</loc>
		<lastmod>2018-05-25T10:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/aenco-unveils-blockchain-venture-for-healthtech-startups/</loc>
		<lastmod>2018-05-25T10:19:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/right-to-try-bill-clears-house-headed-for-trump-signature/</loc>
		<lastmod>2018-05-25T10:17:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/lunaphore-and-vitro-sign-collaboration-agreement-to-develop-ish-protocols-for-rna-dna-targets/</loc>
		<lastmod>2018-05-25T10:10:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/amgen-novartis-closely-watched-migraine-drug-approved/</loc>
		<lastmod>2018-05-21T08:41:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/8000-biopharma-job-opportunities-if-ireland-has-the-ambition/</loc>
		<lastmod>2018-05-21T08:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/franco-quebecois-forum-for-health-innovation-ffqis-successful-second-edition-strengthens-international-partnerships/</loc>
		<lastmod>2018-05-17T15:03:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/bavarian-nordic-announces-acceptance-of-abstracts-and-oral-presentation-at-the-american-society-of-clinical-oncology-asco-annual-meeting/</loc>
		<lastmod>2018-05-17T09:16:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/hkbu-team-develops-metal-based-probes-for-detecting-cancer-biomarkers/</loc>
		<lastmod>2018-05-17T09:08:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/shuwen-debuts-its-codar-arms-pcr-liquid-biopsy-technology-at-asco-2018/</loc>
		<lastmod>2018-05-17T08:53:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/roches-tecentriq-atezolizumab-receives-priority-review/</loc>
		<lastmod>2018-05-16T13:10:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/agc-biologics-enters-into-commercial-supply-agreement-with-macrogenics/</loc>
		<lastmod>2018-05-16T13:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/data-driven-decision-making-and-real-world-evidence-current-and-emerging-trends/</loc>
		<lastmod>2018-05-15T11:51:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/vyriad-signs-a-contract-with-ibm-to-build-an-oncolytic-virus-anti-cancer-vaccines-manufacturing-facility/</loc>
		<lastmod>2018-05-14T08:56:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/emergex-awarded-innovate-uk-grant-to-progress-its-universal-and-pandemic-flu-vaccine/</loc>
		<lastmod>2018-05-14T08:52:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/jjs-janssen-to-acquire-benevir-for-1-billion/</loc>
		<lastmod>2018-05-11T15:51:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/trade-idea-biopharmaceutical-endocyte-hits-4-year-high-on-earnings/</loc>
		<lastmod>2018-05-11T15:47:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/merck-moderna-expand-mrna-cancer-vaccines-partnership/</loc>
		<lastmod>2018-05-11T15:40:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/biopharmaceuticals-market-strongly-guided-by-companies-like-abbvie-amgen-bristol/</loc>
		<lastmod>2018-05-11T15:35:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/putting-the-technicals-into-perspective-for-sino-biopharmaceutical-adr-sbhmy/</loc>
		<lastmod>2018-05-11T15:31:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/takeda-to-acquire-shire-for-62-billion/</loc>
		<lastmod>2018-05-11T15:28:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/lilly-strikes-1-6b-deal-to-buy-i-o-player-armo-biosciences/</loc>
		<lastmod>2018-05-11T15:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/fully-supporting-customer-needs-for-biologics-development-and-manufacturing/</loc>
		<lastmod>2018-05-08T08:34:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/abcam-and-shuwen-biotech-sign-strategic-mou-to-establish-global-alliance-for-companion-diagnostic-cdx-kit-development/</loc>
		<lastmod>2018-05-08T08:30:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/celonic-ag-appoints-soenke-brunswieck-as-vice-president-cell-gene-therapy/</loc>
		<lastmod>2018-05-08T08:13:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/achieving-large-scale-cell-and-gene-therapy-manufacturing/</loc>
		<lastmod>2018-05-04T14:46:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/the-swiss-biotech-association-honors-major-industry-achievements-with-swiss-biotech-success-stories/</loc>
		<lastmod>2018-05-04T10:37:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/new-immunotherapies-need-new-models-to-reflect-new-modalities/</loc>
		<lastmod>2018-05-04T10:33:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/cognitive-pharmacovigilance-business-perspective/</loc>
		<lastmod>2018-05-04T10:27:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/medical-ai-startup-synyi-raises-15-7-m/</loc>
		<lastmod>2018-05-04T10:26:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/transmucosal-drug-delivery-to-the-brain-via-the-nose/</loc>
		<lastmod>2018-05-04T10:24:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/korea-to-invest-33-4m-in-medical-ai-system/</loc>
		<lastmod>2018-05-04T10:24:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/inhalation-advances/</loc>
		<lastmod>2018-05-04T10:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/cellmid-inks-deal-with-chinas-fukangren-bio-pharm/</loc>
		<lastmod>2018-05-04T10:20:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/zen-and-the-art-of-repurposing-drugs/</loc>
		<lastmod>2018-05-04T10:18:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/technology-and-business-trends-in-gene-and-cell-therapies/</loc>
		<lastmod>2018-05-04T09:56:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/structural-analysis-of-biosimilars/</loc>
		<lastmod>2018-05-04T09:52:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/pushing-new-boundaries-technology-and-advanced-analytics-in-late-phase-research/</loc>
		<lastmod>2018-05-04T09:49:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/causes-of-improved-patient-retention-rates-in-phase-iiia-trials/</loc>
		<lastmod>2018-05-04T09:46:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/medical-devices-regulation-the-new-rules/</loc>
		<lastmod>2018-05-04T09:42:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/when-to-patent/</loc>
		<lastmod>2018-05-04T09:38:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/automated-biopharmaceutical-characterisation-from-early-development-to-quality-control-qc/</loc>
		<lastmod>2018-05-04T09:29:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/the-rising-tide-of-functional-data-from-study-of-the-human-and-other-genomes-aiding-in-drug-discovery/</loc>
		<lastmod>2018-05-04T09:25:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/when-the-pursuit-of-gold-standard-analytics-reveals-something-greater/</loc>
		<lastmod>2018-05-04T09:22:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/how-making-screening-is-easy-thanks-to-sprimaging-a-label-free-molecular-interaction-analysis-technology-2/</loc>
		<lastmod>2018-05-04T09:16:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/securing-the-pharmaceutical-supply-chain-the-blockchain-revolution-2/</loc>
		<lastmod>2018-05-04T09:10:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/haselmeier-and-common-sensing-enter-connected-injectable-medicine-collaboration/</loc>
		<lastmod>2018-05-04T08:20:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/q1-earnings-preview-novo-celgene-still-to-come/</loc>
		<lastmod>2018-05-03T10:32:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/for-expensive-new-drugs-biopharma-should-make-money-back-guarantees-mandatory/</loc>
		<lastmod>2018-05-03T10:28:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/expres2ions-u-s-partner-integrated-biotherapeutics-launches-first-expres2-based-research-product/</loc>
		<lastmod>2018-05-02T14:22:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/saunders-all-options-remain-on-the-table-for-allergan/</loc>
		<lastmod>2018-05-01T15:10:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/united-therapeutics-nabs-competing-pah-drug-with-216m-steadymed-buy/</loc>
		<lastmod>2018-05-01T15:03:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/sparks-sells-regulatory-fast-pass-to-jazz-for-110m/</loc>
		<lastmod>2018-05-01T14:58:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/wickham-laboratories-to-present-at-cleanroom-technology-conference-2018/</loc>
		<lastmod>2018-05-01T14:53:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/pfizer-receives-crl-for-biosimilar-to-roches-herceptin/</loc>
		<lastmod>2018-05-01T14:41:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/vivus-restructures-debt-and-gains-access-to-new-capital/</loc>
		<lastmod>2018-05-01T14:32:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/chinese-biopharma-firm-to-create-400-jobs-in-dundalk/</loc>
		<lastmod>2018-05-01T14:29:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/media-information-2018/</loc>
		<lastmod>2018-04-25T13:34:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/adc-bio-secures-1-14m-investment-from-downing-llp-to-finance-innovative-bioconjugation-and-us-expansion/</loc>
		<lastmod>2018-04-24T10:57:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/new-vertical-diffusion-cell-from-copley-scientific-extends-options-for-topical-semisolids-and-transdermal-testing/</loc>
		<lastmod>2018-04-20T09:01:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/sartorius-stedim-biotech-introduces-mini-microcarrier-bioreactor-for-culturing-adherent-cells/</loc>
		<lastmod>2018-04-20T08:54:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/potential-of-icosabutate-as-a-novel-approach-to-the-treatment-of-nash-highlighted-in-late-breaker-at-the-international-liver-congress-2018/</loc>
		<lastmod>2018-04-12T10:00:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.international-biopharma.com/aacr-2018-gamamabs-pharma-to-present-new-data-on-expression-of-anti-mullerian-hormone-type-ii-receptor-in-non-gynecological-cancers-and-on-first-adc-candidate-targeting-amhrii/</loc>
		<lastmod>2018-04-12T09:56:45+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->